Gene · 3158
Papers1,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intestinal mRNA expression profiles associated with mucosal healing in ustekinumab-treated Crohn's disease patients: bioinformatics analysis and prospective cohort validation. | J Transl Med | 2024 | 38926732 | PubTator, text mining | PubMed |
| Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. | Cancer Med | 2024 | 38923428 | PubTator, text mining | PubMed |
| High expression of 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) associated with Diquat-induced damage. | Ecotoxicol Environ Saf | 2024 | 38905939 | PubTator, text mining | PubMed |
| Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's Disease. | J Alzheimers Dis | 2024 | 38875044 | PubTator, text mining | PubMed |
| Reassessing retinal pigment epithelial ketogenesis: Enzymatic assays for ketone body levels provide inaccurate results. | Exp Eye Res | 2024 | 38857822 | PubTator, text mining | PubMed |
Perfluorooctanesulfonic acid exposure leads to downregulation of 3-hydroxy-3-methylglutaryl-CoA synthase 2 expression and upregulation of markers associated with intestinal carcinogenesis in mouse intestinal tissues. | Chemosphere | 2024 | 38754493 | PubTator, text mining | PubMed |
| Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation? | Circulation | 2024 | 38739695 | PubTator, text mining | PubMed |
| Prediction of novel biomarkers for gastric intestinal metaplasia and gastric adenocarcinoma using bioinformatics analysis. | Heliyon | 2024 | 38737262 | PubTator, text mining | PubMed |
| BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine. | Cancer Lett | 2024 | 38704133 | PubTator, text mining | PubMed |
| Adaptive Metabolic Responses Facilitate Blood-Brain Barrier Repair in Ischemic Stroke via BHB-Mediated Epigenetic Modification of ZO-1 Expression. | Adv Sci (Weinh) | 2024 | 38666466 | PubTator, text mining | PubMed |
| Identification of PPAR-related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking. | J Cell Mol Med | 2024 | 38652093 | PubTator, text mining | PubMed |
| Critical sample collection delayed? Urine organic acid analysis can still save the day! A new case of HMG-CoA synthase deficiency. | Mol Genet Metab Rep | 2024 | 38469099 | PubTator, text mining | PubMed |
| Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD. | Am J Physiol Endocrinol Metab | 2024 | 38381399 | PubTator, text mining | PubMed |
| AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication. | Br J Cancer | 2024 | 38361045 | PubTator, text mining | PubMed |
| Metabolic regulation of the hallmarks of stem cell biology. | Cell Stem Cell | 2024 | 38306993 | PubTator, text mining | PubMed |
| Evidence for hypoxia-induced dysregulated cholesterol homeostasis in preeclampsia: Insights into the mechanisms from human placental cells and tissues. | FASEB J | 2024 | 38265294 | PubTator, text mining | PubMed |
| Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer. | Biomolecules | 2024 | 38254664 | PubTator, text mining | PubMed |
| The Identification Distinct Antiviral Factors Regulated Influenza Pandemic H1N1 Infection. | Int J Microbiol | 2024 | 38229736 | PubTator, text mining | PubMed |
| Preclinical Repurposing of Sitagliptin as a Drug Candidate for Colorectal Cancer by Targeting CD24/CTNNB1/SOX4-Centered Signaling Hub. | Int J Mol Sci | 2024 | 38203779 | PubTator, text mining | PubMed |
| Ketone bodies promote epididymal white adipose expansion to alleviate liver steatosis in response to a ketogenic diet. | J Biol Chem | 2024 | 38176653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3158/papers?page=6